June 2026
The global bispecific antibodies market size is valued at USD 17.99 billion in 2025 and is expected to attain around USD 603.13 billion by 2035 at a CAGR of 42.08%.
March 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
September 2026
The immuno-oncology antibodies market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
August 2026
The monoclonal antibodies market size totalled USD 321.83 billion in 2026, with major monoclonal antibodies market players including johnson & johnson, merck, AbbVie, amgen, Pfizer inc, norvatis ag.
April 2026
The global cancer monoclonal antibodies market size reached USD 125.10 billion in 2025 and is predicted to hit around USD 658.07 billion by 2035, with a solid CAGR of 18.06%.
March 2026
The global veterinary monoclonal antibodies market size is estimated to hit around USD 5.62 billion by 2035 increasing from USD 1.74 billion in 2025, with a CAGR of 12.44%.
February 2026
The global research antibodies market size accounted for USD 4.64 billion in 2025 and is projected to hit around USD 7.56 billion by 2035 with a CAGR of 5%.
January 2026
The global bispecific antibody therapeutics contract manufacturing market size was evaluated at USD 9.82 billion in 2025 and is predicted to hit around USD 218.92 billion by 2035, growing at a CAGR of 36.4%.
January 2026
The global next-generation bispecific antibody market size was evaluated at USD 9.53 billion in 2025 and is predicted to hit around USD 52.08 billion by 2035, growing at a CAGR of 18.51%.
December 2025
The polyclonal antibodies market size was estimated at USD 1.70 billion in 2025 and is expected to hit around USD 2.95 billion by 2035 with a CAGR of 5.77%.
July 2024
The global recombinant antibodies market size was estimated at USD 12.40 billion in 2023 and is projected to surpass around USD 23.34 billion by 2033 with a CAGR of 6.53%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com